YouthBio Therapeutics
PrivateTotal Funding Raised
$1.7M
Company Overview
YouthBio Therapeutics is a biotechnology company that develops tissue-specific gene therapies using partial cellular reprogramming to treat age-related diseases, with an initial focus on Alzheimer's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B2C
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
YouthBio Therapeutics Comparables
Compare YouthBio Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Turn Biotechnologies | 79% | |
| Rejuvenate Bio | 77% | |
| Life Biosciences | 76% | |
YouthBio Therapeutics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 99% MoM.
- Apr 16, 2026
Monthly visitors increased 453% MoM, from 75 to 415.
YouthBio Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about YouthBio Therapeutics's valuation, stock price, and market status.